Home > Cashflow Statement > BETA DRUGS

BETA DRUGS
Cash Flow from Operating Activities

    Back to Cashflow Statement
BETA DRUGS is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for BETA DRUGS
Please provide your vote to see the results

BETA DRUGS Last 5 Year Cash Flow from Operating Activities History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Cash Flow from Operating Activities ₹37 Cr₹36 Cr₹31 Cr₹23 Cr₹30 Cr

What is the latest Cash Flow from Operating Activities ratio of BETA DRUGS ?

The latest Cash Flow from Operating Activities ratio of BETA DRUGS is ₹37 Cr based on Mar2026 Consolidated results.
Year Cash Flow from Operating Activities
Mar2026₹37 Cr
Mar2025₹36 Cr
Mar2024₹31 Cr
Mar2023₹23 Cr
Mar2022₹30 Cr

How is Cash Flow from Operating Activities of BETA DRUGS Trending?

Years Cash Flow from Operating Activities % Change
Mar2026 ₹37 Cr
3.16
Mar2025 ₹36 Cr
16.86
Mar2024 ₹31 Cr
32.28
Mar2023 ₹23 Cr
-21.08
Mar2022 ₹30 Cr -

Compare Cash Flow from Operating Activities of peers of BETA DRUGS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BETA DRUGS ₹2,043.2 Cr 2.4% -8% -4.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹437,963.0 Cr 2.7% 1.4% 4.3% Stock Analytics
DIVIS LABORATORIES ₹269,451.0 Cr 4.5% 6.3% 50.8% Stock Analytics
TORRENT PHARMACEUTICALS ₹179,456.0 Cr 1.8% -1.3% 31.4% Stock Analytics
DR REDDYS LABORATORIES ₹113,664.0 Cr 0.8% 12.5% 14.1% Stock Analytics
CIPLA ₹113,246.0 Cr 1.6% 4.4% -9.1% Stock Analytics


BETA DRUGS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
BETA DRUGS

2.4%

-8%

-4.7%

SENSEX

7%

9.6%

-6.7%


You may also like the below Video Courses